Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
ATTAIN-1: Eli Lilly's orforglipron 36 mg achieved 12.4% loss (27.3 lbs) at 72 weeks
Safety signals issued by regulatory agencies prompt further investigation but do not definitively establish causality or confirm that Ozempic causes cancer in humans
Discovery of aptamers and the acceleration of the development of targeting research in ophthalmology
The SURMOUNT 5 study published in the New England Journal of Medicine showed that at week 72, the average weight loss ratio of the Tirzepatide treatment group reached 20.2%, with an average weight loss of 22.8kg, significantly better than that of a single GLP-1 receptor agonist
Reconstituted peptides : Use within 24 hours if fridge fails If longer outage, consider discarding Room temp = rapid degradation Prevention : Small battery-powered cooler, ice packs
US$ 26.57
US$ 26.60
US$ 28.95
US$ 20.21
US$ 21.23
US$ 25.03
US$ 25.33
US$ 20.31
US$ 23.66
US$ 21.87
US$ 27.97
